Clinical Practice Guideline, Issues 17-19U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1995 |
From inside the book
Results 1-5 of 44
Page 25
... statistically significant results that consistently support the guideline recommendation . B Scientific evidence provided by observational studies or by controlled tri- als with less consistent results to support the guideline ...
... statistically significant results that consistently support the guideline recommendation . B Scientific evidence provided by observational studies or by controlled tri- als with less consistent results to support the guideline ...
Page 27
... statistically significant improvement in exercise tolerance in exercise versus control patient groups . 11,12,36,39,62,68,69,146-151 One U.S. trial reported no significant difference between exercise and control subjects.106 Statistically ...
... statistically significant improvement in exercise tolerance in exercise versus control patient groups . 11,12,36,39,62,68,69,146-151 One U.S. trial reported no significant difference between exercise and control subjects.106 Statistically ...
Page 28
... statistically significant improvement in exercise tolerance in intervention versus control patients . These randomized controlled trials are summarized in Tables 1 and 2. The proportion of randomized controlled trials that documented ...
... statistically significant improvement in exercise tolerance in intervention versus control patients . These randomized controlled trials are summarized in Tables 1 and 2. The proportion of randomized controlled trials that documented ...
Page 34
... statistically significant improvements in measures of submaximal exercise tolerance and / or maximal exercise tolerance following exercise training . The beneficial physio- logic adaptations to exercise training included a reduction in ...
... statistically significant improvements in measures of submaximal exercise tolerance and / or maximal exercise tolerance following exercise training . The beneficial physio- logic adaptations to exercise training included a reduction in ...
Page 42
... statistically significant improvements in exercise tolerance . 20,21,26,63,164,173 Six studies described exercise training durations of 13-26 weeks ; 29,71,163,166,168,174 all of them reported statistically significant improvements in ...
... statistically significant improvements in exercise tolerance . 20,21,26,63,164,173 Six studies described exercise training durations of 13-26 weeks ; 29,71,163,166,168,174 all of them reported statistically significant improvements in ...
Other editions - View all
Common terms and phrases
aerobic exercise AHCPR Alzheimer's disease angina angina pectoris assessment baseline exercise test behavioral interventions CABG cardiac rehabilitation exercise cardiac rehabilitation services cardiovascular Category Center cessation rates cholesterol clinicians cognitive control group control patients controlled trials reported coronary artery coronary heart disease coronary patients counseling decreased dementia depression difference between groups documented ECG monitoring ejection fraction elderly evaluation exercise rehabilitation exercise test heart exercise tolerance functional Gender Health heart failure heart rate home exercise impairment increase intensity left ventricular lipid mental status meta-analysis months mortality multifactorial cardiac rehabilitation nicotine gum nicotine patch nicotine replacement therapy nonrandomized controlled studies observational studies panel percent psychiatric psychosocial PTCA randomized controlled trials recommendations reduction rehabilitation exercise training Research risk factor Sample Scientific Evidence Strength scores significant difference significantly smoking cessation specific strategies Strength of Evidence Supervised symptoms test heart rate therapy times/week tion tobacco triglyceride weeks
Popular passages
Page 60 - The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. D. The symptoms are not due to the direct physiological effects of a substance (eg, a drug of abuse, a medication, or other treatment) or a general medical condition (eg, hyperthyroidism).
Page 206 - Agency, as stated by law, is to enhance the quality, appropriateness, and effectiveness of health care services...
Page 18 - A. The development of multiple cognitive deficits manifested by both: 1. Memory impairment (impaired ability to learn new information or to recall previously learned information) 2. One (or more) of the following cognitive disturbances: a. Aphasia (language disturbance) b. Apraxia (impaired ability to carry out motor activities despite intact motor function) c. Agnosia (failure to recognize or identify objects despite intact sensory function) d.
Page 60 - In children and adolescents, can be irritable mood. (2) markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective account or observation made by others...
Page ii - Guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical conditions.
Page 60 - Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning...
Page 105 - Douglas B. Kamerow, MD, MPH Director Office of the Forum for Quality and Effectiveness in Health Care Agency for Health Care Policy and Research Rockville, Maryland Stephen W.
Page 60 - Do not include symptoms that are clearly due to a general medical condition, or mood-incongruent delusions or hallucinations. (1 ) depressed mood most of the day, nearly every day, as indicated by either subjective report (eg, feels sad or empty) or observation made by others (eg, appears tearful). Note: In children and adolescents, can be irritable mood.
Page 172 - Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Page 18 - Substance-induced conditions E. The deficits do not occur exclusively during the course of a delirium F.